Bhatnagar Anish Soleno Therapeutics Inc (SLNO) insider trading activity

SLNO Quotes by TradingView

Bhatnagar Anish is CHIEF EXECUTIVE OFFICER of SOLENO THERAPEUTICS INC. Currently has a direct ownership of 698,462 shares of SLNO, which is worth approximately $33.6 Million. The most recent transaction as insider was on Jan 03, 2025, when has been sold 10,154 shares (Common Stock) at a price of $46.18 per share, resulting in proceeds of $468,911. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 698K
2.93% 3M change
300.73% 12M change
Total Value Held $33.6 Million

Bhatnagar Anish Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 03 2025
SELL
Open market or private sale
$468,911 $46.18 p/Share
10,154 Reduced 1.43%
698,462 Common Stock
Jan 02 2025
SELL
Open market or private sale
$499,164 $45.64 p/Share
10,937 Reduced 1.52%
708,616 Common Stock
Oct 01 2024
SELL
Open market or private sale
$1,077,323 $49.8 p/Share
21,633 Reduced 2.92%
719,553 Common Stock
Aug 29 2024
SELL
Open market or private sale
$2,773,572 $47.5 p/Share
58,391 Reduced 7.3%
741,186 Common Stock
Aug 28 2024
SELL
Open market or private sale
$2,695,344 $47.61 p/Share
56,613 Reduced 6.61%
799,577 Common Stock
Aug 06 2024
SELL
Open market or private sale
$3,106,055 $44.93 p/Share
69,131 Reduced 7.47%
856,190 Common Stock
Aug 05 2024
SELL
Open market or private sale
$2,666,737 $45.81 p/Share
58,213 Reduced 5.92%
925,321 Common Stock
Jul 17 2024
BUY
Grant, award, or other acquisition
-
850,000 Added 46.36%
983,534 Common Stock
Jul 01 2024
SELL
Open market or private sale
$797,776 $41.43 p/Share
19,256 Reduced 12.6%
133,534 Common Stock
Apr 01 2024
SELL
Open market or private sale
$785,582 $41.39 p/Share
18,980 Reduced 11.05%
152,790 Common Stock
Jan 25 2024
SELL
Open market or private sale
$122,054 $48.3 p/Share
2,527 Reduced 1.45%
171,770 Common Stock
Jan 04 2024
BUY
Grant, award, or other acquisition
-
150,000 Added 46.25%
174,297 Common Stock
Dec 11 2023
SELL
Open market or private sale
$3,371,094 $36.09 p/Share
93,408 Reduced 79.36%
24,297 Common Stock
Nov 30 2023
SELL
Open market or private sale
$794,063 $28.65 p/Share
27,716 Reduced 20.41%
108,062 Common Stock
Nov 29 2023
SELL
Open market or private sale
$774,981 $27.85 p/Share
27,827 Reduced 17.01%
135,778 Common Stock
Nov 28 2023
SELL
Open market or private sale
$701,266 $27.31 p/Share
25,678 Reduced 13.57%
163,605 Common Stock
Oct 20 2023
BUY
Exercise of conversion of derivative security
$28,157 $2.92 p/Share
9,643 Added 4.62%
198,926 Common Stock
May 26 2023
BUY
Grant, award, or other acquisition
-
160,602 Added 45.9%
189,283 Common Stock
Mar 31 2022
BUY
Open market or private purchase
-
60,000 Added 12.24%
430,227 Common Stock
Jan 21 2022
SELL
Open market or private sale
$14,442 $0.37 p/Share
39,033 Reduced 9.54%
370,227 Common Stock
Jan 23 2021
SELL
Payment of exercise price or tax liability
$76,631 $2.11 p/Share
36,318 Reduced 0.89%
4,060,780 Common Stock
BA

Bhatnagar Anish

CHIEF EXECUTIVE OFFICER
Redwood City, CA

Track Institutional and Insider Activities on SLNO

Follow SOLENO THERAPEUTICS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SLNO shares.

Notify only if

Insider Trading

Get notified when an Soleno Therapeutics Inc insider buys or sells SLNO shares.

Notify only if

News

Receive news related to SOLENO THERAPEUTICS INC

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on SLNO